Marizomib

Marizomib

SCHEMBL16299707

C[C@@]12OC(=O)C1([C@H](O)[C@H]1C=CCCC1)NC(=O)[C@H]2CCCl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PSMA1PSMA2PSMA3PSMA4PSMA5PSMA6PSMA7PSMA8PSMB1PSMB10PSMB11PSMB2PSMB3PSMB4PSMB5PSMB6PSMB7PSMB8PSMB9

The experimentally established mechanism targets of Marizomib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PSMB5 known ✓ P28074 16/20 1.00
PSMB1 known ✓ P20618 10/20 1.00
PSMB2 known ✓ P49721 10/20 1.00
PSMB11 known ✓ A5LHX3 9/20 1.00
PSMA7 known ✓ O14818 9/20 1.00
PSMA1 known ✓ P25786 9/20 1.00
PSMA2 known ✓ P25787 9/20 1.00
PSMA3 known ✓ P25788 9/20 1.00
PSMA4 known ✓ P25789 9/20 1.00
PSMB8 known ✓ P28062 9/20 1.00
PSMB9 known ✓ P28065 9/20 1.00
PSMA5 known ✓ P28066 9/20 1.00
PSMB4 known ✓ P28070 9/20 1.00
PSMB6 known ✓ P28072 9/20 1.00
PSMB10 known ✓ P40306 9/20 1.00
PSMB3 known ✓ P49720 9/20 1.00
PSMA6 known ✓ P60900 9/20 1.00
PSMA8 known ✓ Q8TAA3 9/20 1.00
PSMB7 known ✓ Q99436 9/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Marizomib SCHEMBL6379031 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL16727767 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL22590161 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL23612709 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL6378694 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL23249771 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL8163424 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL23612710 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL22203978 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7
Marizomib SCHEMBL10262110 1.00 PSMB5 (1.00) PSMB5PSMB1PSMB2PSMB11PSMA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088923-B2 Cyclic-fused beta-lactones and their synthesis THE TEXAS A&M UNIVERSITY SYSTEM (US) 2012-01-03 US disclosed
US-20090062547-A1 CYCLIC-FUSED BETA-LACTONES AND THEIR SYNTHESIS THE TEXAS A&M UNIVERSITY SYSTEM 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062547-A1 CYCLIC-FUSED BETA-LACTONES AND THEIR SYNTHESIS COASY, FASN, OTUB1 PSMB5 7/4885PSMB1 8/4885PSMB2 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.